Big Sister's Bone Marrow Saves the Lives of Her Little Brothers

One pediatric diagnosis of Burkitt's lymphoma in any family is overwhelming. Two would be devastating. But three seems unimaginable.

Yet that is what happened to the Jenkins family of Atlanta, according to a recent Fox News story.

According to the story, three very young Jenkins boys – ranging in age at diagnosis from 2 to 6 – were diagnosed with Burkitt's lymphoma all within the span of a few years. Since Burkitt's is not regarded as a genetic disease, oncologists at the Aflac Cancer Center at Children's Healthcare of Atlanta were baffled – until it was recalled that a rare genetic immune disorder known as XLP could cause it.

All three boys – Will, John, and 2-year-old Matthew – had inherited the disorder. And all three, like tens of thousands of Americans every year, desperately needed a hematopoietic stem cell transplantation. Their problem was the that all patient face: finding a suitable donor.

And that's where big sister Julia, in second grade at the time, stepped in.

She turned out to be a perfect match for two of her brothers, and donated bone marrow while they underwent intense chemotherapy and radiation to wipe out their own immune systems. While the graft took for one of them, it didn't take for another, forcing Julia to donate again, although the second time she donated circulating blood stem cells.

Meanwhile, a donor for the youngest child – for whom Julia was not a match – was found in Texas.

Three years have passed, and all three boys are in good health.

Julia tells Fox News, "Now, I'm not that scared of needles."

She is, however, a lifesaver.

Source: MyFoxAtlanta

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap